Cognitive Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 216 total displayed.

Most recent content

Original Articles
Influence of NOS1 on Verbal Intelligence and Working Memory in Both Patients With Schizophrenia and Healthy Control Subjects

Gary Donohoe; James Walters; Derek W. Morris; Emma M. Quinn; Róisín Judge; Nadine Norton; Ina Giegling; Annette M. Hartmann; Hans-Jürgen Möller; Pierandrea Muglia; Hywel Williams; Valentina Moskvina; Rosemary Peel; Therese O’Donoghue; Michael J. Owen; Michael C. O’Donovan; Michael Gill; Dan Rujescu; Aiden Corvin
Arch Gen Psychiatry 2009; 66: 1045-1054. [Abstract] [Full text] [PDF] [ eSupplement ]  

Past content

Original Contributions
Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia

Catherine Féart; Cécilia Samieri; Virginie Rondeau; Hélène Amieva; Florence Portet; Jean-François Dartigues; Nikolaos Scarmeas; Pascale Barberger-Gateau
JAMA 2009; 302: 638-648. [Abstract] [Full text] [PDF] [ JAMA Report Video ]  

Editorials
Mediterranean Diet and Late-Life Cognitive Impairment: A Taste of Benefit

David S. Knopman
JAMA 2009; 302: 686-687. [Extract] [Full text] [PDF]  

Meta-analysis
Meta-analysis of 41 Functional Neuroimaging Studies of Executive Function in Schizophrenia

Michael J. Minzenberg; Angela R. Laird; Sarah Thelen; Cameron S. Carter; David C. Glahn
Arch Gen Psychiatry 2009; 66: 811-822. [Abstract] [Full text] [PDF]  

Original Articles
Reduced 4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

Philipp M. Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann J. Gertz; Osama Sabri; Johannes Schwarz
Arch Gen Psychiatry 2009; 66: 866-877. [Abstract] [Full text] [PDF] [ eFigures ]  

Original Articles
Altered Prefrontal Glutamate–Glutamine–-Aminobutyric Acid Levels and Relation to Low Cognitive Performance and Depressive Symptoms in Type 1 Diabetes Mellitus

In Kyoon Lyoo; Sujung J. Yoon; Gail Musen; Donald C. Simonson; Katie Weinger; Nicolas Bolo; Christopher M. Ryan; Jieun E. Kim; Perry F. Renshaw; Alan M. Jacobson
Arch Gen Psychiatry 2009; 66: 878-887. [Abstract] [Full text] [PDF] [ eSupplement ]  

Letters to the Editor
Is Elevated Striatal Dopamine Function a Prodromal Sign of Schizophrenia?

Andor E. Simon; Daniel Umbricht
Arch Gen Psychiatry 2009; 66: 916-a-917-a. [Extract] [Full text] [PDF]  

Original Investigations
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population: The 3-City Study

Isabelle Carrière; Annie Fourrier-Reglat; Jean-François Dartigues; Olivier Rouaud; Florence Pasquier; Karen Ritchie; Marie-Laure Ancelin
Arch Intern Med 2009; 169: 1317-1324. [Abstract] [Full text] [PDF] [ eTable ]  

Original Contributions
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

Niklas Mattsson; Henrik Zetterberg; Oskar Hansson; Niels Andreasen; Lucilla Parnetti; Michael Jonsson; Sanna-Kaisa Herukka; Wiesje M. van der Flier; Marinus A. Blankenstein; Michael Ewers; Kenneth Rich; Elmar Kaiser; Marcel Verbeek; Magda Tsolaki; Ezra Mulugeta; Erik Rosén; Dag Aarsland; Pieter Jelle Visser; Johannes Schröder; Jan Marcusson; Mony de Leon; Harald Hampel; Philip Scheltens; Tuula Pirttilä; Anders Wallin; Maria Eriksdotter Jönhagen; Lennart Minthon; Bengt Winblad; Kaj Blennow
JAMA 2009; 302: 385-393. [Abstract] [Full text] [PDF] [ eSupplement ] [ Interactive Figure ]  

Editorials
Use of Alzheimer Disease Biomarkers: Potentially Yes for Clinical Trials but Not Yet for Clinical Practice

Ronald C. Petersen; John Q. Trojanowski
JAMA 2009; 302: 436-437. [Extract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22